HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Fujioka Selected Research

polysaccharide-K

1/2017Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.
12/2013Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
7/2013Protein-bound polysaccharide-K induces apoptosis via mitochondria and p38 mitogen-activated protein kinase-dependent pathways in HL-60 promyelomonocytic leukemia cells.
7/2012Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells.
9/2011Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Fujioka Research Topics

Disease

24Neoplasms (Cancer)
08/2022 - 03/2002
13Carcinogenesis
08/2022 - 11/2013
10Wounds and Injuries (Trauma)
01/2018 - 08/2008
6Infections
01/2018 - 08/2008
3Inflammation (Inflammations)
10/2020 - 03/2017
3Urinary Bladder Neoplasms (Bladder Cancer)
12/2018 - 12/2013
3Carcinoma (Carcinomatosis)
10/2018 - 12/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2016 - 12/2013
3Hemorrhage
01/2016 - 07/2011
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2013 - 09/2011
3Leukemia
07/2013 - 09/2011
2Hypoxia (Hypoxemia)
08/2022 - 04/2018
2Diabetes Mellitus
03/2021 - 04/2009
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 11/2018
2Fibrosis (Cirrhosis)
10/2020 - 06/2019
2Heart Arrest (Cardiac Arrest)
01/2020 - 06/2019
2Body Weight (Weight, Body)
12/2018 - 03/2017
2Adenoma (Adenomas)
10/2018 - 01/2017
2Ulcer
01/2014 - 08/2013
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2012 - 09/2011
1Chronic Renal Insufficiency
08/2022
1Anemia
08/2022
1Insulin Resistance
03/2021
1Liver Neoplasms (Liver Cancer)
03/2021
1Hereditary Angioedemas
01/2021
1Angioedema
01/2021
1Non-alcoholic Fatty Liver Disease
10/2020
1Obesity
10/2020
1Hepatocellular Carcinoma (Hepatoma)
10/2020
1Alcoholic Fatty Liver
10/2020
1Type 2 Diabetes Mellitus (MODY)
10/2020
1Hemophilia A (Haemophilia)
06/2019
1Multi-centric Castleman's Disease
06/2019
1Eccrine Porocarcinoma
05/2019
1Septic Shock (Toxic Shock Syndrome)
04/2019
1Asthma (Bronchial Asthma)
01/2019

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2017 - 09/2011
5polysaccharide-KIBA
01/2017 - 09/2011
4Drinking WaterIBA
01/2020 - 01/2017
4Diethylnitrosamine (N-Nitrosodiethylamine)IBA
08/2017 - 11/2013
3EnzymesIBA
01/2019 - 12/2013
31,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
08/2017 - 01/2017
3Propolis (Bee Bread)IBA
03/2017 - 09/2015
3Ethanol (Ethyl Alcohol)IBA
03/2017 - 09/2015
3diphenylarsinic acidIBA
01/2017 - 11/2013
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2016 - 09/2009
2Hemoglobins (Hemoglobin)IBA
08/2022 - 12/2018
2Biomarkers (Surrogate Marker)IBA
03/2021 - 10/2020
28-Hydroxy-2'-DeoxyguanosineIBA
10/2020 - 08/2017
2Cacodylic Acid (Cacodylate)IBA
01/2020 - 11/2016
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2018 - 11/2013
2NitrosaminesIBA
08/2017 - 01/2017
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
08/2017 - 01/2017
2Dimenhydrinate (DMH)FDA LinkGeneric
08/2017 - 03/2017
2ErbB Receptors (EGF Receptor)IBA
02/2016 - 12/2013
2N-nitroso-tris-chloroethylureaIBA
02/2016 - 12/2013
2propylene dichlorideIBA
05/2015 - 01/2015
2p38 Mitogen-Activated Protein KinasesIBA
07/2013 - 07/2012
2streptococcal polysaccharide type III group BIBA
07/2012 - 09/2011
2Anti-Bacterial Agents (Antibiotics)IBA
08/2008 - 03/2002
1Carbonic Anhydrase InhibitorsIBA
08/2022
1IronIBA
08/2022
1ButylhydroxybutylnitrosamineIBA
08/2022
1Acetazolamide (Diamox)FDA LinkGeneric
08/2022
1Prolyl-Hydroxylase InhibitorsIBA
08/2022
1CateninsIBA
08/2022
1enarodustatIBA
08/2022
1ErythropoietinFDA Link
08/2022
1Small Interfering RNA (siRNA)IBA
03/2021
1Streptozocin (Streptozotocin)FDA Link
03/2021
1berotralstatIBA
01/2021
1BradykininIBA
01/2021
1Plasma KallikreinIBA
01/2021
1LipidsIBA
10/2020
1Arginine (L-Arginine)FDA Link
10/2020
1Glucose (Dextrose)FDA LinkGeneric
10/2020
1Polysaccharides (Glycans)IBA
10/2020
1Histones (Histone)IBA
01/2020
1AminesIBA
12/2019
1acetoaceto-o-toluidideIBA
12/2019
1Reticulin (Reticular Fiber)IBA
06/2019
1tocilizumab (atlizumab)FDA Link
06/2019
1erucylphosphocholineIBA
05/2019
1PlasticsIBA
05/2019
1AndrogensIBA
12/2018

Therapy/Procedure

10Therapeutics
04/2019 - 08/2008
4Perforator Flap
01/2018 - 01/2014
3Skin Transplantation (Skin Grafting)
12/2017 - 10/2010
3Radiotherapy
10/2014 - 07/2011
3Free Tissue Flaps
09/2013 - 01/2011
3Debridement
10/2012 - 08/2008
2Myocutaneous Flap
01/2018 - 10/2014
2Enteral Nutrition (Feeding, Tube)
01/2016 - 06/2009
2Replantation
01/2015 - 10/2012
2Palliative Care (Palliative Therapy)
08/2013 - 10/2010
1Oral Administration
01/2021
1Cardiopulmonary Resuscitation (CPR)
01/2020
1Heart-Assist Devices
01/2020
1General Anesthesia
01/2019
1Cystectomy
12/2018